Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study
11 of 49 authors shown in byline order.
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Institutions
- Perelman School of Medicine, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Acrylamides; Morpholines; Pyrazoles; Pyrimidines; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Bispecific; Injections, Subcutaneous; Mutation; Adult
- PubMed ID
- 38857463
- PubMed Central ID
- PMC11469630
- Open access
- Yes, open
- Added to directory
- Source checked